FDA Device recall Z-2936-2020
Parvovirus B19 IgG EIA kit Part No. V519IGUS
- FDA Device
- Class II
- ongoing
- Published 2020-09-09
On 2020-09-09 the FDA classified a Class II recall of Parvovirus B19 IgG EIA kit Part No. V519IGUS by Diasorin, citing printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2936-2020 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2020-07-17 |
| Published | 2020-09-09 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Diasorin |
| Distribution | CA, CT, IL, MA, MI, MN, NC, NJ, NY, VA, WI |
Product
Parvovirus B19 IgG EIA kit Part No. V519IGUS
Reason
Printed label inside the box lid of the Parvovirus has the incorrect Lot Specific Constant value
Identifiers
| code_info | Lot 71440040AA |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: ongoing.
Other recalls by Diasorin
- DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060
FDA Device · Class II · 2024-12-18 · Diasorin - DiaSorin LIAISON HSV-2 Type Specific IgG, REF 310620
FDA Device · Class II · 2024-01-31 · Diasorin - LIAISON 1-84 PTH Assay - Product Usage: is an in vitro chemiluminescent immunoassay (CLIA) intended for the quantitative determination of p…
FDA Device · Class II · 2021-04-07 · Diasorin - LIAISON Estradiol II Gen, 310680, 310680-CN The DiaSorin LIAISON Estradiol II Gen assay is a chemiluminescent immunoassay (CLIA) intended f…
FDA Device · Class II · 2016-11-30 · Diasorin - DiaSorin, PRO-Trac II Tacrolimus ELISA kit, REF 32400 and 32400-CN. Product Usage: The PRO-Trac II Tacrolimus ELISA kit is an in vitro reag…
FDA Device · Class II · 2015-04-29 · Diasorin
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2936-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.